Advances in bispecific biotherapeutics for the treatment of cancer
The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases
Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide
Novel mithramycins abrogate the involvement of protein factors in the transcription of cell cycle control genes
The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway
Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells
Rebuilding the balance of STAT1 and STAT3 signalings by fusaruside, a cerebroside compound, for the treatment of T-cell-mediated fulminant hepatitis in mice
Evidence for ligand-specific conformations of the histamine H2-receptor in human eosinophils and neutrophils
Concerted actions of the catechol O -methyltransferase and the cytosolic sulfotransferase SULT1A3 in the metabolism of catecholic drugs
Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemia
A uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropionate induces cell damage to proximal tubular cells via the generation of a radical intermediate
Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597